Results 171 to 180 of about 89,575 (313)

Administration of belimumab prior to standard immunosuppression in patients with early active lupus hinders accrual of new EULAR/ACR criteria within the first 12 months of treatment. [PDF]

open access: yesLupus Sci Med
Gatto M   +10 more
europepmc   +1 more source

STATEMENT OF CASH FLOWS - A MEASURE OF OPERATIONAL PERFORMANCE ON AN ACCRUAL BASIS

open access: yesChallenges of the Knowledge Society, 2011
Statement of cash flows presents useful information about changing the company's financial position, allowing to assess the enterprise’s ability to generate future cash flows and cash equivalents in the operating, investing and financing activities and their appropriate use. Treasury of an economic entity can be considered its strong point.
openaire   +1 more source

Generalized Cash Flow Taxation [PDF]

open access: yes
We show the unique form that must be taken by a tax system based entirely on realization accounting to implement a uniform capital income tax, or, equivalently, a uniform wealth tax.
Alan J. Auerbach, David F. Bradford
core  

Advancing Employee Voice Through Insights From Democratic Innovations

open access: yesHuman Resource Management Journal, EarlyView.
ABSTRACT Employee voice has long attracted interest from academics, policymakers, and practitioners in light of its myriad benefits. To date, employee voice researchers have identified a wide array of voice practices that are organized and understood through a core set of dimensions.
Simon Pek, Lorin Busaan
wiley   +1 more source

The Political Economy of Patent Buyouts

open access: yesThe RAND Journal of Economics, EarlyView.
ABSTRACT Incentivizing innovation through buyouts may alleviate the social costs associated with patent power, but the political economy and feasibility of this potentially important financing mechanism have been understudied. We study an international setting of countries with different innovation and financing capabilities, and where financing ...
Amal Ahmad   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy